Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121908587
rs121908587
Entrez Id: 5156
Gene Symbol: PDGFRA
PDGFRA
CUI: C0346421
Disease:
Chronic eosinophilic leukemia
0.040 GeneticVariation BEFREE T674I FIP1L1-PDGFRα in a subset of chronic eosinophilic leukemia (CEL) is a gatekeeper mutation that is resistant to many tyrosine kinase inhibitors (TKIs) (e.g., imatinib, nilotinib and dasatinib), similar to T315I Bcr-Abl. 24472312 2014
dbSNP: rs121908587
rs121908587
Entrez Id: 5156
Gene Symbol: PDGFRA
PDGFRA
CUI: C0346421
Disease:
Chronic eosinophilic leukemia
0.040 GeneticVariation BEFREE In conclusion, S116836 is active against WT and T674I FIP1L1-PDGFRα-expressing cells, and may be a prospective agent for the treatment of HES/CEL. 25431951 2014
dbSNP: rs121908587
rs121908587
Entrez Id: 5156
Gene Symbol: PDGFRA
PDGFRA
CUI: C0346421
Disease:
Chronic eosinophilic leukemia
0.040 GeneticVariation BEFREE Thus, sorafenib is clinically active in imatinib-resistant FIP1L1-PDGFRalpha T674I CEL, but the rapid emergence of other mutants may limit the response duration. 19212337 2009
dbSNP: rs121908587
rs121908587
Entrez Id: 5156
Gene Symbol: PDGFRA
PDGFRA
CUI: C0346421
Disease:
Chronic eosinophilic leukemia
0.040 GeneticVariation BEFREE Our data suggest that low doses of sorafenib could be efficient for the treatment of FIP1L1-PDGFRA-positive CEL and could be used to overcome resistance to imatinib associated with the T674I mutation. 16645167 2006